These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11967646)

  • 21. Psychotic and compulsive symptoms in Parkinson's disease.
    Verbaan D; van Rooden SM; Visser M; Marinus J; Emre M; van Hilten JJ
    Mov Disord; 2009 Apr; 24(5):738-44. PubMed ID: 19133665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of Parkinson's disease in natural population].
    Huang JB; Zhang ZX; Wu JX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):19-22. PubMed ID: 12905811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia in Parkinson's disease.
    Robottom BJ; Weiner WJ
    Int Rev Neurobiol; 2009; 84():229-44. PubMed ID: 19501721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis in Parkinson's disease.
    Wood B; Walker R
    Mov Disord; 2005 Dec; 20(12):1636-40. PubMed ID: 16108011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in Parkinson's disease and its association with dementia and depression.
    Hughes TA; Ross HF; Mindham RH; Spokes EG
    Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease.
    Cakit BD; Saracoglu M; Genc H; Erdem HR; Inan L
    Clin Rehabil; 2007 Aug; 21(8):698-705. PubMed ID: 17846069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
    Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D
    Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between motor subtypes and psychopathology in Parkinson's disease.
    Reijnders JS; Ehrt U; Lousberg R; Aarsland D; Leentjens AF
    Parkinsonism Relat Disord; 2009 Jun; 15(5):379-82. PubMed ID: 18977165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Respiratory function impairment in patients with Parkinson's disease--a consideration on the possible pathogenetic relation to autonomic dysfunction].
    Yamada H; Murahashi M; Takahashi H; Kai K; Shibuya S; Jimi T; Wakayama Y; Yamada M
    Rinsho Shinkeigaku; 2000 Feb; 40(2):125-30. PubMed ID: 10835931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthostatic hypotension, balance and falls in Parkinson's disease.
    Matinolli M; Korpelainen JT; Korpelainen R; Sotaniemi KA; Myllylä VV
    Mov Disord; 2009 Apr; 24(5):745-51. PubMed ID: 19133666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mental disorders in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1992; 38():115-27. PubMed ID: 1491244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.